Citations

Clear

9383 citation(s) found for "Thomas, PS".

The effect of the COVID-19 pandemic on hospitalization for acute exacerbations of chronic obstructive pulmonary disease
Saunders, Hollie , Thomas, Colleen S. , Balavenkataraman, Arvind , Helgeson, Scott A.

Mayo Clinic

Lung India | December 24, 2024 | Volume: 42 | Issue: 1 | Pages: 69-71

10.4103/lungindia.lungindia_398_24 | PMID 39718925 Get It

Examining Changes in Ulnar Collateral Ligament Reconstruction Surgery Patterns Among Professional Baseball Players
Jones, Margaret T. , Erickson, Jacob L. , Taylor, Wayne A., Bittner, Michael , Jagim, Andrew R , Almonroeder, Thomas Gus , Taylor, Wayne A., Jagim, Andrew R.

Mayo Clinic

Clinical Journal of Sport Medicine | December 24, 2024 | Volume: 35 | Issue: 4 | Pages: 465-470

10.1097/jsm.0000000000001319 | PMID 39718384 Get It

Objective: To retrospectively analyze publicly available elbow ulnar collateral ligament reconstruction (UCLR) injury data for professional baseball players. Design: Descriptive epidemiology study. Setting: A retrospective analysis using an open-source database was performed. The database contained all known UCLR surgeries among Major League Baseball (MLB) and Minor League Baseball (MiLB) players. Participants: In total, 1801 professional male professional baseball pitchers (age: 24.5 ± 3.9 years) who have undergone UCLR between 1974 and 2024. Main Outcome Measures: The number of UCLR procedures each year. Independent Variables: Change-point analysis was used to identify changes in the number of UCLR surgeries over time among MLB and MiLB players. For MLB players, number of UCLR surgeries from 1974 to 2023 was analyzed, while for MiLB players, data starting from 1981 to 2024 were analyzed. Results: For MLB players, 3 change points were identified, occurring around 1989 (95% confidence interval [CI], 1988–1990), 2000 (95% CI, 2000–2000), and 2012 (95% CI, 2011–2017). For MiLB players, 3 change points were identified occurring around 2001 (95% CI, 2001–2001), 2009 (95% CI, 2008–2010), and 2013 (95% CI, 2013–2015). Conclusions: Overall, there has been a rise in the number of UCLR surgeries per year for the past 50 years in professional baseball, with distinct time points identified, representing increases in the number of UCLR surgeries each year. A higher number of UCLR surgeries are performed per year in the MiLB than in the MLB.
cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics
Aldape, Kenneth , Capper, David , Giannini, Caterina , Gilbert, Mark R. , Hawkins, Cynthia , Hench, Juergen , Jacques, Thomas S. , Louis, David N. , Mueller, Sabine , Nasrallah, MacLean P. , Solomon, David A. , von Deimling, Andreas , Giannini, Caterina , Gilbert, M. Jean , Hawkins, Cynthia , Hench, Jürgen , Jacques, Thomas S , Orr, Brent A , Nasrallah, MacLean , Pfister, Stefan M , Sahm, Felix , Snuderl, Matija , Varlet, Pascale , Solomon, David A , Capper, David , Deimling, Andreas von , Jones, David , Orr, Brent A. , Pfister, Stefan M. , Sahm, Felix , Snuderl, Matija , Wesseling, Pieter

Mayo Clinic

Neuro-Oncology Advances | December 23, 2024 | Volume: 7 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdae228 | PMID 39902391 Get It

Abstract Genome-wide DNA methylation signatures correlate with and distinguish central nervous system (CNS) tumor types. Since the publication of the initial CNS tumor DNA methylation classifier in 2018, this platform has been increasingly used as a diagnostic tool for CNS tumors, with multiple studies showing the value and utility of DNA methylation-based classification of CNS tumors. A Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (cIMPACT-NOW) Working Group was therefore convened to describe the current state of the field and to provide advice based on lessons learned to date. Here, we provide recommendations for the use of DNA methylation-based classification in CNS tumor diagnostics, emphasizing the attributes and limitations of the modality. We emphasize that the methylation classifier is one diagnostic tool to be used alongside previously established diagnostic tools in a fully integrated fashion. In addition, we provide examples of the inclusion of DNA methylation data within the layered diagnostic reporting format endorsed by the World Health Organization (WHO) and the International Collaboration on Cancer Reporting. We emphasize the need for backward compatibility of future platforms to enable accumulated data to be compatible with new versions of the array. Finally, we outline the specific connections between methylation classes and CNS WHO tumor types to aid in the interpretation of classifier results. It is hoped that this update will assist the neuro-oncology community in the interpretation of DNA methylation classifier results to facilitate the accurate diagnosis of CNS tumors and thereby help guide patient management.
Implementing the 2024 ACC/AHA Multisocietal PAD guidelines into clinical practice: Key changes from the 2016 guidelines
Cohoon, Kevin P. , Henkin, Stanislav , Tomihama, Roger T. , Thomas, Sneha , Porres‐Aguilar, Mateo , Brunton, Nichole , Hornacek, Deborah , Secemsky, Eric A. , Brunton, Nichole E , Porres-Aguilar, Mateo , Tomihama, Roger , Henkin, Stanislav , Secemsky, Eric A

Mayo Clinic

Vascular Medicine | December 23, 2024 | Volume: 30 | Issue: 1 | Pages: 110-113

10.1177/1358863x241306354 | PMID 39713878 Get It

Longitudinal cognitive performance of participants with sporadic early onset Alzheimer's disease from LEADS
Hammers, Dustin B. , Eloyan, Ani , Taurone, Alexander, Thangarajah, Maryanne, Gao, Sujuan , Polsinelli, Angelina J. , Kirby, Kala, Dage, Jeffrey L. , Aisen, Paul, Reman, Rema, Joie, Renaud La , Clark, David W. , Day, Gregory S. , Duara, Ranjan , Graff‐Radford, Neill R. , Grant, Ian , Honig, Lawrence S., Johnson, Erik C. B. , Masdeu, Joseph C. , Mendez, Mario F. , Onyike, Chiadi U. , Riddle, Meghan , Rogalskı, Emily , Salloway, Steven, Sha, Sharon J. , Turner, Raymond Scott , Wingo, Thomas S. , Carrillo, Marı́a C., Rabinovici, Gil D. , Apostolova, Liana G. , Carrillo, María C. , Day, Gregory S , La Joie, Renaud , Rabinovici, Gil D , Wingo, Thomas S , Dage, Jeffrey L , Hammers, Dustin B , Beckett, Laurel , Kirby, Kala, Nudelman, Kelly , Reman, Rema, Lagarde, Julien , Atri, Alireza , Duara, Ranjan , Honig, Lawrence S. , Jones, David T. , Masdeu, Joseph C , Womack, Kyle , Musiek, Erik , Salloway, Steve , Wolk, S. J. , Dickerson, Bradford Clark

Mayo Clinic

Alzheimer's & Dementia | December 23, 2024 | Volume: 21 | Issue: 2 | Pages: No page available

10.1002/alz.14439 | PMID 39713873 Get It

Abstract INTRODUCTION Early‐onset Alzheimer's disease (EOAD) manifests prior to the age of 65, and affects 4%–8% of patients with Alzheimer's disease (AD). The current analyses sought to examine longitudinal cognitive trajectories of participants with early‐onset dementia. METHODS Data from 307 cognitively normal (CN) volunteer participants and those with amyloid‐positive EOAD or amyloid‐negative cognitive impairment (EOnonAD) were compared. Cognitive trajectories across a comprehensive cognitive battery spanning 42 months were examined using mixed‐effects modeling. RESULTS The EOAD group displayed worse cognition at baseline relative to EOnonAD and CN groups, and more aggressive declines in cognition over time. The largest effects were observed on measures of executive functioning domains, while memory declines were blunted in EOAD. DISCUSSION EOAD declined 2–4× faster than EOnonAD, and EOAD pathology is not restricted to memory networks. Early identification of deficits is critical to ensure that individuals with sporadic EOAD can be considered for treatment using disease‐modifying medications. Highlights Represents the most comprehensive longitudinal characterization of sporadic EOAD to date. The trajectory of cognitive declines was steep for EOAD participants and worse than for other groups. Executive functioning measures exhibited the greatest declines over time in EOAD.
Differences in baseline cognitive performance between participants with early‐onset and late‐onset Alzheimer's disease: Comparison of LEADS and ADNI
Hammers, Dustin B. , Eloyan, Ani , Thangarajah, Maryanne, Taurone, Alexander, Gao, Sujuan , Polsinelli, Angelina J. , Kirby, Kala, Dage, Jeffrey L. , Aisen, Paul , Reman, Rema, Joie, Renaud La , Clark, David A. , Day, Gregory S. , Duara, Ranjan , Graff‐Radford, Neill R. , Masdeu, Joseph C. , Mendez, Mario F. , Onyike, Chiadi U. , Riddle, Meghan , Grant, Ian , Rogalskı, Emily , Johnson, Erik C. B. , Salloway, Steven, Sha, Sharon J. , Turner, Raymond Scott , Wingo, Thomas S. , Carrillo, María C. , Rabinovici, Gil D. , Apostolova, Liana G. , Day, Gregory S , La Joie, Renaud , Rabinovici, Gil D , Wingo, Thomas S , Dage, Jeffrey L , Hammers, Dustin B , Beckett, Laurel , Kirby, Kala, Nudelman, Kelly , Lagarde, Julien , Atri, Alireza , Clark, David, Duara, Ranjan , Honig, Lawrence S. , Jones, David T. , Masdeu, Joseph C , Womack, Kyle , Musiek, Erik , Salloway, Steve , Wolk, David A. , Dickerson, Bradford Clark

Mayo Clinic

Alzheimer's & Dementia | December 23, 2024 | Volume: 21 | Issue: 1 | Pages: No page available

10.1002/alz.14218 | PMID 39711228 Get It

Abstract INTRODUCTION Early‐onset Alzheimer's disease (EOAD) and late‐onset Alzheimer's disease (LOAD) share similar amyloid etiology, but evidence from smaller‐scale studies suggests that they manifest differently clinically. Current analyses sought to contrast the cognitive profiles of EOAD and LOAD. METHODS Z‐ score cognitive‐domain composites for 311 amyloid‐positive sporadic EOAD and 314 amyloid‐positive LOAD participants were calculated from baseline data from age‐appropriate control cohorts. Z‐ score composites were compared between AD groups for each domain. RESULTS After controlling for cognitive status, EOAD displayed worse visuospatial, executive functioning, and processing speed/attention skills relative to LOAD, and LOAD displayed worse language, episodic immediate memory, and episodic delayed memory. DISCUSSION Sporadic EOAD possesses distinct cognitive profiles relative to LOAD. Clinicians should be alert for non‐amnestic impairments in younger patients to ensure proper identification and intervention using disease‐modifying treatments. Highlights Both early‐onset Alzheimer's disease (EOAD) and late‐onset Alzheimer's disease (LOAD) participants displayed widespread cognitive impairments relative to their same‐aged peers. Cognitive impairments were more severe for EOAD than for LOAD participants in visuospatial and executive domains. Memory and language impairments were more severe for LOAD than for EOAD participants Results were comparable after removing clinical phenotypes of posterior cortical atrophy (PCA), primary progressive aphasia (lv‐PPA), and frontal‐variant AD.
Imaging and Nonsurgical Management of Renal Masses
Jorgenson, Laura C. , Navin, Patrick J. , Thompson, Scott M. , Takahashi, Edwin A. , Schmit, Grant D. , Potretzke, Theodora A. , Venkatesh, Sudhakar K. , Potretzke, Aaron M. , Stish, Bradley J. , Atwell, Thomas D. , Adamo, Daniel, Thompson, Scott , Takahashi, Edwin A , Schmit, Grant, Potretzke, Theodora , Venkatesh, Sudhakar K , Stish, Bradley, Atwell, Thomas D , Navin, Patrick , Adamo, Daniel A.

Mayo Clinic

RadioGraphics | December 19, 2024 | Volume: 45 | Issue: 1 | Pages: No page available

10.1148/rg.240093 | PMID 39700039 Get It

Radiologists play a key role in the management of renal masses, and it is important to understand the nonsurgical treatment options for solid renal masses, typical imaging findings after treatment, common complications, and methods to avoid pitfalls.
A Prospective, Randomized, Noninferiority Study to Evaluate the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation Compared with Standard Ureteroscopy: 30-Day Results of the ASPIRE Study
Matlaga, Brian R., Johnson, Brett A. , Page, Jay, Wolf, J. Stuart, Preminger, Glenn M. , Jones, Loren, Sobol, Ilya , Stern, Karen , Cuellar, David, Cobb, Kaitlan, Barsky, Robert I, Medairos, Robert, Marguet, Charles G., Nimmagadda, Naren , Chi, Thomas , Johnson, Brett , Stern, Karen L , Mueller, Thomas J. , Jones, Loren, White, Mark, Levin, Michael

Mayo Clinic

Journal of Endourology | December 19, 2024 | Volume: 39 | Issue: 1 | Pages: 10-18

10.1089/end.2024.0602 | PMID 39699687 Get It

Purpose: We report the first multicenter, prospective, randomized noninferiority controlled trial of steerable ureteroscopic renal evacuation (SURE) for nephrolithiasis treatment. Materials and Methods: Candidates for laser lithotripsy ≥18 years with ≥1 renal stone ≥7 mm and 7–20 mm stone burden were randomized 1:1 SURE vs ureteroscopy (URS). SURE was performed using the CVAC Aspiration System, a novel steerable irrigation–aspiration catheter. The primary efficacy end point was noninferiority in stone-free rate (SFR) based on zero residual fragments (RFs) 30 days postprocedure on noncontrast computed tomography. Secondary end points were superiority tests, stone clearance (percent stone volume reduction), residual stone volume (RSV), SFR (no RF >2 mm), and SFR (no RF >4 mm) 30 days postprocedure. Results: Of the subjects, 123 were randomized and 101 qualified for efficacy analysis (SURE 46 vs URS 55). Despite randomization, baseline URS stone volume was higher (SURE 485.0 ± 432.5 mm 3 vs URS 713.3 ± 558.5 mm 3 ). The primary noninferiority end point was achieved (SURE SFR 48% vs URS SFR 49%, p = 0.027, −1.3% [90% confidence interval; −18%, 15%]). Stone clearance was significantly higher for SURE vs URS subjects (SURE 96.9 ± 5.6% vs URS 92.9 ± 11.6%, p = 0.036); RSV was significantly lower (SURE 14.3 ± 3 0.9 mm 3 vs URS 70.2 ± 144.9 mm 3 , p = 0.012). SURE stone clearance and RSV were independent of baseline stone volume, but for URS degraded with increasing baseline stone volume. Safety was comparable between groups. Conclusions: SFR for SURE subjects was noninferior compared with URS subjects; stone clearance and RSV were significantly better with SURE, independent of baseline stone volume.
Consensus Recommendations for Studies of Outflow Facility and Intraocular Pressure Regulation Using Ex Vivo Perfusion Approaches
Acott, Ted S. , Fautsch, Michael P. , Mao, Weiming , Huang, Alex S. , Kelley, Mary J. , Aga, Mini , Borrás, Terete, Bovenkamp, Diane E. , Chowdhury, Uttio Roy, Clark, Abbot F. , Dibas, Mohammed, Elliott, Michael H. , Faralli, Jennifer A., Gong, Haiyan , Kaufman, Paul L., Keller, Kate E. , Kuehn, Markus H. , Li, Hoi Lam, Lin, Shan C. , Liu, Yutao , McDonnell, Fiona , McDowell, Colleen M. , Mzyk, Philip , Nair, K. Saidas , Overby, Darryl R. , Peters, Donna M. , Raghunathan, VijayKrishna, Rao, Ponugoti Vasantha , Roddy, Gavin W. , Sharif, Najam A. , Shim, Myoung Sup , Sun, Yang , Thomson, Benjamin R. , Willoughby, Colin E. , Freddo, Thomas F., Fuchshofer, Rudolf , Hill, Kamisha R. , Karimi, Alireza , Kizhatil, Krishnakumar , Kopcyznski, Casey C., Patel, Gaurang , Pattabiraman, Padmanabhan P. , Prasanna, Ganesh , Samples, E. Griffen, Samples, John R., Steel, Cynthia, Subramanian, Preeti, Sugali, Chenna Kesavulu , Sherwood, Joseph M. , Wong, Cydney A. , Zode, Gulab , White, Elizabeth , Liu, Yutao , Ethier, C. Ross , Bhattacharya, Sanjoy K. , Du, Yiqin , Herberg, Samuel , Johnstone, Murray , Kelly, Ruth A. , Križaj, David , Lieberman, Raquel L. , McLellan, Gillian J. , Raghunathan, VijayKrishna, Rao, Ponugoti Vasantha , Toris, Carol B. , Zhang, Hao F. , Liton, Paloma B. , Peng, Michael , Reina‐Torres, Ester , Strohmaier, Clemens , Youngblood, Hannah A. , Stamer, William Daniel

Mayo Clinic

Investigative Ophthalmology & Visual Science | December 18, 2024 | Volume: 65 | Issue: 14 | Pages: 32

10.1167/iovs.65.14.32 | PMID 39693082 Get It

Management of Persistent Hypernasality After Pharyngeal Flap by Revision Palatoplasty With Use of MRI to Aid Surgical Decision Making
Chee-Williams, Jessica L. , Perry, Jamie L. , Verhey, Erik M., Sitzman, Thomas J. , Sitzman, Thomas J , Chee-Williams, Jessica L , Perry, Jamie L , Singh, Davinder

Mayo Clinic

The Cleft Palate Craniofacial Journal | December 18, 2024 | Volume: 63 | Issue: 4 | Pages: 900-905

10.1177/10556656241307740 | PMID 39692547 Get It

Objective Describe surgical decision making and outcomes in a series of patients with persistent VPI after pharyngeal flap placement that were all treated with revision palatoplasty. Design Retrospective, case series. Participants Five patients with nonsyndromic cleft palate and persistent hypernasality following a pharyngeal flap. On MRI, 3 patients presented with an incohesive levator veli palatini muscle, and 4 patients had a pharyngeal flap that was below the palatal plane. Interventions One patient underwent straight-line intravelar veloplasty (IVVP), 2 patients underwent pharyngeal flap take-down and IVVP, and 2 patients underwent pharyngeal flap take-down and palate lengthening with buccal myomucosal flaps. Main Outcome Measure Pre- and postoperative resonance. Results Four of five patients (80%) achieved normal resonance 12 months postoperation. Conclusions Revision palatoplasty may be an effective approach for treating patients with persistent hypernasality following a pharyngeal flap. MRI may aid in surgical selection based on patient-specific anatomical findings.